Tetrahydro-4-oxo-3-furancarboxylic Acid Methyl Ester, is used for the preparation of fused-pyrimidine derivatives as a series of novel GPR119 agonists.
Negoro, K., et al.: Bioorg. Med. chem., 20, 6442 (2012); Goto, T., et al.: Bioorg. Med. Chem. Lett., 23, 3325 (2013);
400-821-0725
沪ICP备17019645号
